Xia, Tianjiao; Roper, Stephen - In: Industry and Innovation 16 (2009) 6, pp. 593-612
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive and protracted new product development (NPD) processes, intensive regulation and extensive alliance activity. Policy regimes and operating environments differ markedly, however. Here we examine how...